RA Capital's SPAC Research Alliance III increases shares offered by 50% ahead of $75 million IPO
Research Alliance III, a blank check company formed by RA Capital targeting drug development and healthtech, raised the proposed deal size for its upcoming IPO on Wednesday. The New York, NY-based company now plans to raise $75 million by offering 7.5 million...read more


